Research for the treatment of inflammation of small airways in asthma
Not Applicable
- Conditions
- asthma
- Registration Number
- JPRN-UMIN000010284
- Lead Sponsor
- Department of Respiratory Medicine, Graduate School on Medicine, Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
tuberculosis, oneumonia, interstitial pneumonia, lung cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effects on small airways inflammation of
- Secondary Outcome Measures
Name Time Method Effects on various clinical indices including adherence
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are implicated in small airway inflammation in asthma as studied in JPRN-UMIN000010284?
How does the intervention in JPRN-UMIN000010284 compare to standard-of-care therapies for asthma-related small airway inflammation?
Which biomarkers correlate with treatment response in small airway inflammation trials sponsored by Kyoto University's Respiratory Medicine department?
What adverse events are associated with experimental therapies targeting small airway inflammation in asthma, and how are they managed?
Are there synergistic combination therapies or competitor drugs for small airway inflammation in asthma under investigation in 2013-era trials?